CJC-1295 (No DAC) + Ipamorelin Blend 10mg
CJC-1295 (No DAC) + Ipamorelin Blend 10mgCJC-1295 (No DAC) + Ipamorelin Blend 10mgCJC-1295 (No DAC) + Ipamorelin Blend 10mgCJC-1295 (No DAC) + Ipamorelin Blend 10mgCJC-1295 (No DAC) + Ipamorelin Blend 10mg
Axin Peptides

CJC-1295 (No DAC) + Ipamorelin Blend 10mg

$0.00

CJC-1295 (No DAC) + Ipamorelin Blend 10mg

The CJC-1295 (No DAC) + Ipamorelin Blend combines two laboratory-grade research peptides in a single 10mg vial, providing researchers with a convenient format for controlled in-vitro investigation.

CJC-1295 without DAC is a modified peptide analogue commonly studied for its short-duration activity and interaction with growth hormone–releasing pathways. Ipamorelin is a selective growth hormone secretagogue frequently examined in receptor-binding, cellular signalling and peptide interaction research.

Combining both compounds allows researchers to investigate their individual and complementary characteristics within controlled laboratory environments.

Each Axin Research Peptides vial is independently manufactured and batch tested using High-Performance Liquid Chromatography and Mass Spectrometry. A corresponding Certificate of Analysis is provided for transparency and verification.

Product Details

  • CJC-1295 (No DAC) + Ipamorelin blend
  • Total vial content: 10mg
  • Laboratory-tested identity and purity
  • Batch-specific Certificate of Analysis
  • Supplied as a lyophilised research material

Research Use Only

This product is intended strictly for laboratory research and analytical purposes. It is not intended for human or veterinary use, consumption, diagnosis, treatment or therapeutic application.